AMV
CTCP Sản xuất Kinh doanh Dược và Trang thiết bị Y tế Việt Mỹ · HNX
1,400
Declining sharply · Net margin −61.42%, −60.89pp YoY
On a TTM 2026Q1 basis, AMV posted a very sharp profit drop versus the same period, showing that pressure has clearly fed through to the bottom line — margins have been compressing consistently over multiple periods. More notably, operating cash flow is significantly negative relative to profit — this is pressure that needs close monitoring.
Revenue TTM
VND 98bn
−70.1%
Net Margin
−61.42%
−60.9pp year on year
ROE
-3.7%
TTM